Sharechat Logo

Cavotec mulls offshore listing, blames poor NZX liquidity

Wednesday 20th October 2010

Text too small?

Cavotec MSL Holdings, the global engineering group and owner of Christchurch-based MoorMaster, is looking at a secondary offshore listing, blaming poor liquidity and falling volumes on the NZX.

The proposed listing on the Nasdaq OMX First North stock exchange is seen as a move that will provide the company with additional avenues to raise capital, while closing the gap between a listing in New Zealand and the company’s expanding manufacturing base outside the Pacific Rim region.

“Lower liquidity on the NZX, coupled with falls in overall trading volumes over the past year, has underlined the necessity of seeking alternative routes to capitalise on future opportunities,” said chief executive Ottonel Popesco.

Sweden’s Handelsbanken has been appoint to look at the feasibility of a second listing on the First North bourse, which is operated by various Nordic NASDAQ OMX exchanges in Copenhagen, Helsinki, Iceland and Stockholm.

Shares rose 1.8% to $2.85, and have risen also 10% this year.

Lifting interest in the NZX bourse has been an ongoing issue for the stock exchange operator, and in April, returning fund manager Paul Glass flagged Australia’s market as a better option for his investments due to the local market's “awful” liquidity.

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Cavotec profit up, bullish on earnings outlook
Cavotec wins 4.1 million euro contracts to supply airport ground equipment